Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 11Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 693Neoplasms 610Prostatic Neoplasms 320Lung Neoplasms 309Colorectal Neoplasms 281Carcinoma, Non-Small-Cell Lung 253Pancreatic Neoplasms 178Carcinoma, Hepatocellular 169Stomach Neoplasms 143Multiple Myeloma 127Ovarian Neoplasms 121Melanoma 116Colonic Neoplasms 114Brain Neoplasms 108Hematologic Neoplasms 106Head and Neck Neoplasms 103Urinary Bladder Neoplasms 102Leukemia, Myeloid, Acute 100Esophageal Neoplasms 100Disease 97Liver Neoplasms 92Uterine Cervical Neoplasms 90Neoplasm Metastasis 89Lymphoma 86Rectal Neoplasms 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Endometrial Neoplasms 78Carcinoma, Renal Cell 74Leukemia 65Sarcoma 63

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Bone Marrow Failure Disorders × 1 year × Clear all
NCT06056908 2026-04-06

SDSR

Boston Children's Hospital

Recruiting
5,000 enrolled
Classical hematologyOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Shwachman-Diamond Syndrome, Leukemia, Neutropenia

NCT04618081 2025-07-08

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Celgene

Completed
151 enrolled
Lymphoid

Bone Marrow Failure Disorders, Lymphoma, Lymphoma, Non-Hodgkin, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡